The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-Spain approves Pfizer shots for under-60s who got AstraZeneca first dose -El Pais

Tue, 18th May 2021 21:46

(Updates with reported approval)

MADRID, May 18 (Reuters) - Spain's public health commission
has approved a proposal by the health ministry that Spaniards
under 60 who have received a first dose of AstraZeneca's
vaccine get a second shot of the coronavirus vaccine produced by
Pfizer Inc, El Pais newspaper reported on Tuesday,
citing unnamed sources.

The proposal will affect about 1.5 million Spaniards who
received the AstraZeneca shot before the government banned it
for those aged under 60 due to blood clot concerns.

A study by the government's Carlos III Health Institute
found that mixing and matching the two drugs was both safe and
effective.
(Reporting by Victoria Waldersee; Editing by Andrei Khalip and
Peter Cooney)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.